Low-dose Rivaroxaban: is it a safe alternative in Chinese older patients?
Yue YuWei YangWenyuan LiGe GaoDan LuoYue WuXianming SuPublished in: European journal of clinical pharmacology (2023)
10 mg once daily rivaroxaban may provide survival benefits for elderly patients with NVAF.